Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Suzhou Ribo Life Science Company

Tracked across 2 events · 14 articles · First seen May 06, 2026 · Last active Jul 02, 2026

Sentiment
70
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: Suzhou Ribo Life Science Company achieved a key milestone in its research collaboration with Boehringer Ingelheim for MASH therapies, highlighting its siRNA discovery and liver targeted delivery capabilities and solidifying its position as a strategic partner.
May 06, 2026 · 7 articles
4 70
Tech
Impact: Suzhou Ribo Life Science Company, along with its subsidiary KC Pharmaceuticals, has achieved a significant milestone in its siRNA partnership with KC Pharmaceuticals, Inc. for MASH therapies, which is expected to positively impact its stock and reputation.
Jul 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Suzhou Ribo Life Science Company live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.